ICONIC THERAPEUTICS
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1. hI-con1 binds tissue factor (TF), triggering natural killer cells to selectively destroy pathologic neovascular blood vessels. Such cells include choroidal neovascularization (CNV) associated with wet age-related macular deg... eneration (wet AMD) and TF-expressing cancer cells and tumor-associated pathologic blood vessels (PBV). In addition to this cell-mediated cytotoxicity, hI-con1 may also interrupt the positive feedback loop between tissue factor and vascular endothelial growth factor (VEGF), thereby reducing VEGF levels. Phase 1 studies with hl-con1 are complete and no dose limited toxicities were observed. Evidence of dose-related biologic activity was observed.
ICONIC THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2002-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.iconictherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(650) 437-1000
Email Addresses:
[email protected]
Total Funding:
82.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Nginx Euro
Similar Organizations
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
HBM Partners
HBM Partners investment in Venture Round - Iconic Therapeutics
JLABS
JLABS investment in Venture Round - Iconic Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Venture Round - Iconic Therapeutics
ATDC
ATDC investment in Venture Round - Iconic Therapeutics
MPM Capital
MPM Capital investment in Venture Round - Iconic Therapeutics
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Venture Round - Iconic Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Venture Round - Iconic Therapeutics
Elm Street Ventures
Elm Street Ventures investment in Venture Round - Iconic Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - Iconic Therapeutics
Diem Bioventures
Diem Bioventures investment in Venture Round - Iconic Therapeutics
Official Site Inspections
http://www.iconictherapeutics.com
- Host name: staticip2.multiscreensite.com
- IP address: 100.24.208.97
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149